Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional bleomycin for keloids using electronic pneumatic jet injector (split-lesion, double-blind, randomized, placebo-controlled)
2020-003228-18Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in keloid comparing Bleomycin half-lesion with Placebo half-lesion (2 arms). Primary endpoint: Change in keloid volume at 4 weeks after three treatments. Started Mar 2021; status: active.
02
Drugs
bleomycin
03
Conditions
keloid
Beyond the preview
Go deeper on 2020-003228-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003228-18.